PROSPECTIVE ASSESSMENT OF THE DIAGNOSTIC PERFORMANCE OF ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE BIOPSY IN INTRA-ABDOMINAL MASS LESIONS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200823001

Enrollment

100

Registered

2020-08-23

Start date

2017-03-21

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE BIOPSY (EUS-FNB) ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE BIOPSY (EUS-FNB), Diagnostic performance, Intraabdominal mass lesion

Interventions

FNB was performed using a 22 G Acquire needle (Boston Scientific) with slow pull technique

Experimental Device

EUS-FNB

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Consecutive patients referred for EUS-guided tissue acquisition for intra-abdominal solid lesions, for example, pancreatic mass, lymph node or subepithelial lesion would be included.

Exclusion criteria

Exclusion criteria: Patients with coagulopathy, thrombocytopenia (platelet count < 50,000 mm3), altered anatomy, contraindications for conscious sedation, pregnancy and those who cannot provide informed consent would be excluded.

Design outcomes

Primary

Measure	Time frame
diagnostic performance of endoscopic ultrasound guided fine needle biopsy (EUS-FNB) At the end of intervention sensitivity, specificity, PPV, NPV, AUROC	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactNonthalee Pausawasdi

Faculty of Medicine Siriraj Hospital

nonthaleep7@gmail.com6624197281

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Jun 27, 2026